<?xml version="1.0" encoding="utf-8"?>
<iati-activities xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" version="2.03" generated-datetime="2026-02-14T16:03:57.1673656+01:00" linked-data-default="http://data-service.theglobalfund.org/api">
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-IND-T-FIND-1</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Strengthening sustainable Laboratory Diagnostic Network of RNTCP and Joint Effort for Elimination of Tuberculosis (JEET) - India (01-Jan-2018-31-Mar-2021)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">India, Tuberculosis, Foundation for Innovative New Diagnostics India (FIND)This program has the following goals: To achieve a rapid decining burden of TB morbidity and mortality while working towards elimination of TB in India by 2025. The objectives of this program are: Systematically engage the private provides  with an increase in case notification to 2 million cases annually.  Improving treatment adherence and treatment support byadoption of iCT tools and partnerships.  Strengthen linkages with the Pharmacovigilance program of india ( PvPI) for monitoring, identification and detection of signals..  Health system strengthening with focus on mechanisms for critical mangement reforms, restructuring HR and Financial norms.</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="15" role="2">
			<narrative xml:lang="en">Foundation for Innovative New Diagnostics India</narrative>
		</participating-org>
		<participating-org type="15" role="3">
			<narrative xml:lang="en">Foundation for Innovative New Diagnostics India</narrative>
		</participating-org>
		<participating-org type="15" role="4">
			<narrative xml:lang="en">Foundation for Innovative New Diagnostics India</narrative>
		</participating-org>
		<other-identifier ref="IND-T-FINDP01" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="3" />
		<activity-date type="1" iso-date="2018-01-01" />
		<activity-date type="2" iso-date="2018-01-01" />
		<activity-date type="3" iso-date="2021-03-31" />
		<activity-date type="4" iso-date="2021-03-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Gyongyver, JAKAB</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>gyongyver.jakab@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="IN" percentage="100">
			<narrative xml:lang="en">India</narrative>
		</recipient-country>
		<sector vocabulary="1" code="12110" percentage="56">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="44">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="46">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 control and containment including health systems strengthening</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="9">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="37">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="8">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2019-01-01" />
			<period-end iso-date="2019-12-31" />
			<value currency="USD" value-date="2018-01-01">7398787.99</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2021-01-01" />
			<period-end iso-date="2021-12-31" />
			<value currency="USD" value-date="2018-01-01">16842006.02</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2020-01-01" />
			<period-end iso-date="2020-12-31" />
			<value currency="USD" value-date="2018-01-01">19947486.86</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2018-01-01" />
			<period-end iso-date="2018-12-31" />
			<value currency="USD" value-date="2018-01-01">4615440.63</value>
		</budget>
		<transaction ref="f7e5063f-d1aa-4891-a7f5-890623f1a2c3">
			<transaction-type code="2" />
			<transaction-date iso-date="2019-09-19" />
			<value currency="USD" value-date="2019-09-19">13779980.24</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to IND-T-FINDP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="7fcd185a-dca2-4ff1-9187-14a7383cc099">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-09-02" />
			<value currency="USD" value-date="2020-09-02">8020361.62</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to IND-T-FINDP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="60a3067d-e775-4655-a34a-bae0caafccbf">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-11-19" />
			<value currency="USD" value-date="2020-11-19">-6913120.62</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to IND-T-FINDP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="44cba445-a232-4597-a031-39fcf17b83d5">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-09-02" />
			<value currency="USD" value-date="2020-09-02">-5532286.24</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to IND-T-FINDP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1d127782-2fd7-4d62-9bf0-98913ff28698">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-09-15" />
			<value currency="USD" value-date="2021-09-15">-14350483.68</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to IND-T-FINDP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="25b48941-9a68-4625-9dee-50fcc78964e4">
			<transaction-type code="2" />
			<transaction-date iso-date="2019-09-19" />
			<value currency="USD" value-date="2019-09-19">-5659699.94</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to IND-T-FINDP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="bbe31529-f1ec-4ab4-8542-9ae8c2089eca">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-09-15" />
			<value currency="USD" value-date="2021-09-15">0.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to IND-T-FINDP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="8ff6b1db-2562-4fc0-b129-28cf6940ea9c">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-02-15" />
			<value currency="USD" value-date="2018-02-15">16274982.26</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to IND-T-FINDP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="90aebd79-9f8f-4073-b6ab-499c596c8bf6">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-11-19" />
			<value currency="USD" value-date="2020-11-19">28833504.68</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to IND-T-FINDP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="72d3c98b-a9d5-43dd-bf7a-7bfc4e2e6bd2">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-05-25" />
			<value currency="USD" value-date="2022-05-25">22514.49</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to IND-T-FINDP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c9f3f5d5-afbc-43b5-b0c7-e9533b6ab187">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-06-02" />
			<value currency="USD" value-date="2022-06-02">22514.49</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="fdec4355-a8db-4c4f-b6b6-a34a6be0a916">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-12-12" />
			<value currency="USD" value-date="2019-12-12">4704353.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="73b2cb29-c27e-4d08-bcd8-5e129993ed08">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-11-25" />
			<value currency="USD" value-date="2020-11-25">3172214.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ae8dd1da-516f-4696-a1bc-b9e2fde6ab6f">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-02-07" />
			<value currency="USD" value-date="2019-02-07">4860294.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c7865342-957e-4582-98de-9a476f695631">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-09-09" />
			<value currency="USD" value-date="2020-09-09">1107241.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="42e40933-b186-42fa-84b1-f425e4e336f4">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-07-31" />
			<value currency="USD" value-date="2018-07-31">4712470.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d93cff98-a615-4835-9bc8-6a034e7925ea">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-09-20" />
			<value currency="USD" value-date="2019-09-20">1825792.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="0ad1dce4-8c36-46de-b2c3-a44babff954e">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-04-03" />
			<value currency="USD" value-date="2020-04-03">1717549.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="06088806-ea7f-40f7-9deb-4bd8606369bf">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-04-23" />
			<value currency="USD" value-date="2021-04-23">11310807.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="3554e7d8-d00c-4550-9ab6-098b9fe60a6b">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-02-16" />
			<value currency="USD" value-date="2018-02-16">1042518.32</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/IND-T-FIND" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for IND-T-FINDP01</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-09-30" />
					<target value="10858" />
					<actual value="14925" />
				</period>
				<period>
					<period-start iso-date="2020-10-01" />
					<period-end iso-date="2021-03-31" />
					<target value="73055" />
					<actual value="37305" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-09-30" />
					<target value="68074" />
					<actual value="25834" />
				</period>
				<period>
					<period-start iso-date="2019-10-01" />
					<period-end iso-date="2020-03-31" />
					<target value="53132" />
					<actual value="41756" />
				</period>
				<period>
					<period-start iso-date="2018-10-01" />
					<period-end iso-date="2019-03-31" />
					<target value="24905" />
					<actual value="29125" />
				</period>
				<period>
					<period-start iso-date="2019-04-01" />
					<period-end iso-date="2019-09-30" />
					<target value="38188" />
					<actual value="40572" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2019-10-01" />
					<period-end iso-date="2020-03-31" />
					<target value="70.00" />
					<actual value="80.00" />
				</period>
				<period>
					<period-start iso-date="2020-10-01" />
					<period-end iso-date="2021-03-31" />
					<target value="70.00" />
					<actual value="82.90" />
				</period>
				<period>
					<period-start iso-date="2019-04-01" />
					<period-end iso-date="2019-09-30" />
					<target value="70.00" />
					<actual value="85.10" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-09-30" />
					<target value="70.00" />
					<actual value="84.10" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for IND-T-FINDP01</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2019-04-01" />
					<period-end iso-date="2019-09-30" />
					<target value="179" />
					<actual value="159.34" />
				</period>
				<period>
					<period-start iso-date="2019-10-01" />
					<period-end iso-date="2020-03-31" />
					<target value="197" />
					<actual value="159.34" />
				</period>
				<period>
					<period-start iso-date="2020-10-01" />
					<period-end iso-date="2021-03-31" />
					<target value="209" />
					<actual value="131.08" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed</narrative>
				</title>
				<period>
					<period-start iso-date="2019-10-01" />
					<period-end iso-date="2020-03-31" />
					<target value="86.86" />
					<actual value="74.13" />
				</period>
				<period>
					<period-start iso-date="2019-04-01" />
					<period-end iso-date="2019-09-30" />
					<target value="76.63" />
					<actual value="68.37" />
				</period>
				<period>
					<period-start iso-date="2020-10-01" />
					<period-end iso-date="2021-03-31" />
					<target value="94.74" />
					<actual value="81.82" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2019-10-01" />
					<period-end iso-date="2020-03-31" />
					<target value="56.00" />
					<actual value="48.00" />
				</period>
				<period>
					<period-start iso-date="2019-04-01" />
					<period-end iso-date="2019-09-30" />
					<target value="48.00" />
					<actual value="47.81" />
				</period>
				<period>
					<period-start iso-date="2020-10-01" />
					<period-end iso-date="2021-03-31" />
					<target value="65.00" />
					<actual value="49.11" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Notification of RR-TB and/or MDR-TB cases – Percentage of notified cases of bacteriologically confirmed, drug resistant RR-TB and/or MDR-TB as a proportion of all estimated RR-TB and/or MDR-TB cases</narrative>
				</title>
				<period>
					<period-start iso-date="2019-10-01" />
					<period-end iso-date="2020-03-31" />
					<target value="54.68" />
					<actual value="44.88" />
				</period>
				<period>
					<period-start iso-date="2020-10-01" />
					<period-end iso-date="2021-03-31" />
					<target value="63.69" />
					<actual value="53.52" />
				</period>
				<period>
					<period-start iso-date="2019-04-01" />
					<period-end iso-date="2019-09-30" />
					<target value="45.69" />
					<actual value="44.88" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for IND-T-FINDP01</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2019-10-01" />
					<period-end iso-date="2020-03-31" />
					<target value="30" />
					<actual value="32" />
				</period>
				<period>
					<period-start iso-date="2020-10-01" />
					<period-end iso-date="2021-03-31" />
					<target value="24" />
					<actual value="32" />
				</period>
			</indicator>
		</result>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-IND-T-FIND-2</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Strengthening health systems for sustainable access to quality diagnosis, engagement of private sector, management of latent TB and amplifying community action for achieving TB elimination in India - India (01-Apr-2021-31-Mar-2024)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">India, Tuberculosis, Foundation for Innovative New Diagnostics India (FIND)This program has the following goals: To achieve a rapid decline in burden of TB, morbidity and mortality to achieve the Sustainable Development Goals of 80% reduction in incidence and 90% reduction in deaths by 2025; five years earlier than the stipulated timeline.. The objectives of this program are: Build, strengthen and sustain enabling policies, empowered institutions, multi-sectoral collaborations, engaged communities, and human resources with enhanced capacities to create a supportive ecosystem to END TB..  Prevent the emergence of TB in susceptible populations..  To train  and engage selected TB Champions to improve community awareness and preparedness for TB and COVID-19 through advanced communications skilling.  To facilitate the formation and strengthening of local rapid response teams, led by TB Champions in coordination with local health officers and CHOs, to ensure that people with TB/COVID receive timely and appropriate services</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="15" role="2">
			<narrative xml:lang="en">Foundation for Innovative New Diagnostics India</narrative>
		</participating-org>
		<participating-org type="15" role="3">
			<narrative xml:lang="en">Foundation for Innovative New Diagnostics India</narrative>
		</participating-org>
		<participating-org type="15" role="4">
			<narrative xml:lang="en">Foundation for Innovative New Diagnostics India</narrative>
		</participating-org>
		<other-identifier ref="IND-T-FINDP02" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="4" />
		<activity-date type="1" iso-date="2021-04-01" />
		<activity-date type="2" iso-date="2021-04-01" />
		<activity-date type="3" iso-date="2024-03-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Gyongyver, JAKAB</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>gyongyver.jakab@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="IN" percentage="100">
			<narrative xml:lang="en">India</narrative>
		</recipient-country>
		<sector vocabulary="1" code="12110" percentage="51">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="49">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID diagnostics and testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="7">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 control and containment including health systems strengthening</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 CSS: Community-based organizations institutional capacity building</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 CSS: Community-led advocacy and research</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 CSS: Social mobilization</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="27">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Infection prevention and control, and protection of the health workforce</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="14">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="32">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="8">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="9">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2021-01-01" />
			<period-end iso-date="2021-12-31" />
			<value currency="USD" value-date="2021-04-01">10722546.04</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2024-01-01" />
			<period-end iso-date="2024-12-31" />
			<value currency="USD" value-date="2021-04-01">10500815.39</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2025-01-01" />
			<period-end iso-date="2025-12-31" />
			<value currency="USD" value-date="2021-04-01">1647795.83</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2022-01-01" />
			<period-end iso-date="2022-12-31" />
			<value currency="USD" value-date="2021-04-01">17361689.99</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2023-01-01" />
			<period-end iso-date="2023-12-31" />
			<value currency="USD" value-date="2021-04-01">22244514.76</value>
		</budget>
		<transaction ref="1d53b52d-c898-4df6-99c9-ce6fea65217e">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-01-21" />
			<value currency="USD" value-date="2025-01-21">4520990.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d73824d2-1941-4f17-af0f-a085e34ffeea">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-12-12" />
			<value currency="USD" value-date="2024-12-12">-8479580.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e39691a1-fd4e-47c3-b341-4551d55155c7">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-12-12" />
			<value currency="USD" value-date="2024-12-12">45661.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f3dd9e61-467b-418c-98c6-d02acda391c3">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-12-18" />
			<value currency="USD" value-date="2021-12-18">-5923662.46</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="175b58ac-6930-4274-bc50-411b8a52670b">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-12-18" />
			<value currency="USD" value-date="2021-12-18">18089965.97</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="7db4c30b-74be-46ec-ba92-de804e214d78">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-06-30" />
			<value currency="USD" value-date="2023-06-30">-2213.12</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="15ca309f-5d8a-462c-9281-c7f505028877">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-12-16" />
			<value currency="USD" value-date="2022-12-16">15637911.89</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2cc05474-8b44-40bf-b8d1-f48d2592c990">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-12-16" />
			<value currency="USD" value-date="2022-12-16">-3999663.58</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="25b5255c-6812-474a-8e61-e62c8c9f26ab">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-10-07" />
			<value currency="USD" value-date="2022-10-07">-3609.73</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d7afff06-a248-4cf2-a154-c54a431d06a5">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-12-19" />
			<value currency="USD" value-date="2023-12-19">-2552127.18</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="16326dc2-91ed-49d1-864c-9b87ef2453fe">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-05-03" />
			<value currency="USD" value-date="2021-05-03">18549407.04</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ef11d9f9-e421-49d4-a8a9-840ac815e6d4">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-12-19" />
			<value currency="USD" value-date="2023-12-19">14557885.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5f6b8c9b-d4b4-491e-9f52-dfc1245585ce">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-07-04" />
			<value currency="USD" value-date="2024-07-04">-143.51</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="9bcd3d47-4151-43d3-af5e-3e6173352564">
			<transaction-type code="7" />
			<transaction-date iso-date="2024-07-01" />
			<value currency="USD" value-date="2024-07-01">-143.51</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP02.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="49fc75ba-ce86-48c4-b7ca-acc264ae40b9">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-06-20" />
			<value currency="USD" value-date="2023-06-20">2390115.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="4121dc70-335c-4831-b6d6-41641dbc3266">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-12-18" />
			<value currency="USD" value-date="2024-12-18">45661.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="21ccd8f0-4050-4b4f-bab3-08767cd841d5">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-08-12" />
			<value currency="USD" value-date="2021-08-12">3124551.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5d052c0a-2371-4fe5-a18a-707e2e950155">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-11-18" />
			<value currency="USD" value-date="2021-11-18">230845.58</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="6f0f10b5-2885-4d46-9989-a0233fec0d44">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-05-07" />
			<value currency="USD" value-date="2021-05-07">1931742.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f5e0b123-cf61-48b9-9961-84db857f93a8">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-12-06" />
			<value currency="USD" value-date="2022-12-06">1721885.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="874a2af4-c691-47a8-8c0e-5b28b19292dd">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-03-27" />
			<value currency="USD" value-date="2024-03-27">3809572.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b8ab67ff-c06f-4a1b-88e0-4c73dbfb8d34">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-09-23" />
			<value currency="USD" value-date="2021-09-23">7338606.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="7dfbffae-ffd0-4005-a318-08b0f6d95693">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-08-18" />
			<value currency="USD" value-date="2022-08-18">6935.76</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b31d2688-1227-49e9-83c3-0eaff4874d88">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-08-11" />
			<value currency="USD" value-date="2022-08-11">1968656.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="77881244-5f6f-497d-b053-c2ec14df65f7">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-12-16" />
			<value currency="USD" value-date="2025-12-16">2113797.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="bfa95c2a-1069-4d5c-8de6-0f98d8e4f7f4">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-10-06" />
			<value currency="USD" value-date="2022-10-06">12075.63</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="181c0391-22be-4db1-887b-135c5aaa4824">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-12-20" />
			<value currency="USD" value-date="2022-12-20">3537690.98</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="be37ff7f-ba72-4aa6-8d28-cc80a5dbd300">
			<transaction-type code="7" />
			<transaction-date iso-date="2023-06-01" />
			<value currency="USD" value-date="2023-06-01">-2213.12</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP02.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c52301ac-d841-4ee3-a35f-e5dd20050142">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-08-29" />
			<value currency="USD" value-date="2024-08-29">527132.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2aa79f4b-a87a-4a1c-b55c-4f92a22a5e39">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-12-21" />
			<value currency="USD" value-date="2021-12-21">10380750.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="526047a9-b0d6-4677-84e5-30c2bf6b94b8">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-12-20" />
			<value currency="USD" value-date="2023-12-20">1741601.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e8cde183-4e3a-406e-9ce2-0a73c12a4ac5">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-06-20" />
			<value currency="USD" value-date="2023-06-20">4332266.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="83296d91-f03c-4bb8-82c7-efa596f58946">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-01-23" />
			<value currency="USD" value-date="2025-01-23">763505.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="eab70410-bc6c-4833-85ab-3d98473aaf29">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-12-20" />
			<value currency="USD" value-date="2022-12-20">2806488.89</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a556baec-8257-46d4-bf30-f56c44d4e0b9">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-12-20" />
			<value currency="USD" value-date="2022-12-20">19223.84</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ea365d38-947c-43d5-bc91-cf04cabc3951">
			<transaction-type code="7" />
			<transaction-date iso-date="2022-10-06" />
			<value currency="USD" value-date="2022-10-06">-3609.73</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to IND-T-FINDP02.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">Foundation for Innovative New Diagnostics India (FIND)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/IND-T-FIND" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for IND-T-FINDP02</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">MDR TB-Other 1: Percentage of CBNAAT laboratories (GeneXpert) showing adequate performance on External Quality Assurance</narrative>
				</title>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2023-03-31" />
					<target value="95.00" />
					<actual value="97.90" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="94.98" />
					<actual value="97.80" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="94.97" />
					<actual value="97.90" />
				</period>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2022-03-31" />
					<target value="95.00" />
					<actual value="97.80" />
				</period>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="95.02" />
					<actual value="98.10" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2024-03-31" />
					<target value="95.00" />
					<actual value="98.10" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of people in contact with TB patients who began preventive therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="80849" />
					<actual value="46650" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="70262" />
					<actual value="45335" />
				</period>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2022-03-31" />
					<target value="38686" />
					<actual value="36462" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2023-03-31" />
					<target value="140524" />
					<actual value="112236" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2024-03-31" />
					<target value="159803" />
					<actual value="105170" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-09-30" />
					<target value="78954" />
					<actual value="58520" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="70262" />
					<actual value="66901" />
				</period>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2021-09-30" />
					<target value="7354" />
					<actual value="2275" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="31332" />
					<actual value="34187" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TCP Other-2: Percentage of contacts initiated on TPT completing treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="85.00" />
					<actual value="90.40" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="80.00" />
					<actual value="80.80" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-09-30" />
					<target value="85.00" />
					<actual value="87.90" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2023-03-31" />
					<target value="80.00" />
					<actual value="84.20" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2024-03-31" />
					<target value="85.00" />
					<actual value="88.90" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="80.00" />
					<actual value="84.50" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="75.00" />
					<actual value="85.40" />
				</period>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2021-09-30" />
					<target value="75.00" />
					<actual value="85.00" />
				</period>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2022-03-31" />
					<target value="75.00" />
					<actual value="85.20" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of DST laboratories showing adequate performance on External Quality Assurance</narrative>
				</title>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2024-03-31" />
					<target value="95.10" />
					<actual value="71.00" />
				</period>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2022-03-31" />
					<target value="58.00" />
					<actual value="55.60" />
				</period>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="95.06" />
					<actual value="71.00" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-09-30" />
					<target value="88.89" />
					<actual value="73.50" />
				</period>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2021-09-30" />
					<target value="51.85" />
					<actual value="51.90" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="76.54" />
					<actual value="59.30" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2023-03-31" />
					<target value="76.50" />
					<actual value="59.30" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="58.03" />
					<actual value="55.60" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="65.43" />
					<actual value="61.70" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TCP Other-3: Number of People with DS TB who received person-centered care and support services from TB champions during reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2024-03-31" />
					<target value="80640" />
					<actual value="103680" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2023-03-31" />
					<target value="89280" />
					<actual value="90915" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="48960" />
					<actual value="47777" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="40320" />
					<actual value="43138" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-09-30" />
					<target value="40320" />
					<actual value="52933" />
				</period>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="40320" />
					<actual value="50747" />
				</period>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2022-03-31" />
					<target value="48000" />
					<actual value="43529" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="48000" />
					<actual value="43529" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">MDR TB-Other 2: Percentage of Truenat laboratories showing adequate performance on External Quality Assurance</narrative>
				</title>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2023-03-31" />
					<target value="85.00" />
					<actual value="87.80" />
				</period>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2022-03-31" />
					<target value="80.00" />
					<actual value="90.80" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="80.00" />
					<actual value="90.80" />
				</period>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="90.00" />
					<actual value="98.50" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2024-03-31" />
					<target value="90.00" />
					<actual value="98.50" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="85.00" />
					<actual value="87.80" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
				</title>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2021-09-30" />
					<target value="26670" />
					<actual value="17493" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="8890" />
					<actual value="7717" />
				</period>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2022-03-31" />
					<target value="35560" />
					<actual value="25210" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TCP Other-1: Percentage of household contacts screened</narrative>
				</title>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="70.01" />
					<actual value="72.70" />
				</period>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="80.15" />
					<actual value="85.60" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-09-30" />
					<target value="79.84" />
					<actual value="85.40" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="75.00" />
					<actual value="72.90" />
				</period>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2022-03-31" />
					<target value="70.00" />
					<actual value="62.50" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="75.00" />
					<actual value="79.90" />
				</period>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2021-09-30" />
					<target value="69.99" />
					<actual value="24.20" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2024-03-31" />
					<target value="80.00" />
					<actual value="85.50" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2023-03-31" />
					<target value="75.00" />
					<actual value="76.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TCP-Other 4: Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated from private/non-governmental facilities</narrative>
				</title>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="89.00" />
					<actual value="88.60" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-09-30" />
					<target value="89.00" />
					<actual value="88.60" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="88.00" />
					<actual value="87.80" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2023-03-31" />
					<target value="88.00" />
					<actual value="87.80" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2024-03-31" />
					<target value="89.00" />
					<actual value="88.60" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for IND-T-FINDP02</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="30" />
					<actual value="35" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-09-30" />
					<target value="27" />
					<actual value="23" />
				</period>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="25" />
					<actual value="23" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB incidence rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="164" />
					<actual value="199" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-09-30" />
					<target value="174" />
					<actual value="199" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for IND-T-FINDP02</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse</narrative>
				</title>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-09-30" />
					<target value="1859804" />
					<actual value="1658010.33" />
				</period>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="2012400" />
					<actual value="1658010.33" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people diagnosed with TB who experienced self-stigma that inhibited them from seeking and accessing TB services</narrative>
				</title>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="14.38" />
					<actual value="8.32" />
				</period>
			</indicator>
		</result>
	</iati-activity>
</iati-activities>